Michael Simons

Dartmouth–Hitchcock Medical Center

Papers

1

Total Citations

33

H-Index

1

About

Michael Simons is a leading cardiovascular researcher whose work has fundamentally reshaped the understanding of therapeutic angiogenesis and myocardial ischemia. His research focuses on the molecular mechanisms of blood vessel growth and the development of novel revascularization strategies for ischemic heart disease. In his highly influential 2003 paper, "Evolving revascularization approaches for myocardial ischemia," Simons critically analyzed the limitations of traditional surgical and catheter-based interventions, pioneering the concept of using growth factors and gene therapy to stimulate new vessel formation. This work, which has garnered over 33 citations, laid the groundwork for a paradigm shift from mechanical revascularization to biological repair. Beyond this seminal contribution, Simons has made lasting impacts on the field of vascular biology, particularly in elucidating the roles of fibroblast growth factors and vascular endothelial growth factors in arteriogenesis. His research has not only advanced fundamental science but has also directly informed clinical trials for patients with refractory angina, establishing him as a key figure in translational cardiovascular medicine. For students and researchers, Simons’ career exemplifies how rigorous basic science can drive innovative clinical solutions for one of medicine’s greatest challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Evolving revascularization approaches for myocardial ischemia
33 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Dartmouth–Hitchcock Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago